• $3.2M
    Market Cap
  • -98.85%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-625,477
+179.58%
-223,721
-9.83%
-248,102
+0.07%
-247,919
-3.18%
Depreciation and Amortization Expense
997
N/A
N/A
N/A
297
-82.16%
1,665
-16.46%
Total Operating Expenses
18.2M
-68.25%
57.3M
+3,628.93%
1.5M
-13.54%
1.8M
-10.76%
Operating Profit
-18.2M
-68.25%
-57.3M
+3,628.93%
-1.5M
-13.54%
-1.8M
-10.76%
Interest Income
161
+1,688.89%
9
-85.00%
60
+66.67%
36
-99.36%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-532,821
-6.33%
Interest Income and Expense and Net
161
+1,688.89%
9
-85.00%
60
+100.01%
-532,785
-5.40%
Total Nonoperating Income and Expense
-677,141
-58.84%
-1.6M
+297.76%
-413,611
-59.20%
-1.0M
+40.37%
Income before Taxes
-18.9M
-67.99%
-58.9M
+2,922.23%
-1.9M
-30.13%
-2.8M
+2.85%
Income Taxes
N/A
N/A
N/A
N/A
-129,132
-0.55%
-129,841
+136.17%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-19.8M
-66.41%
-58.9M
+3,136.60%
-1.8M
-31.57%
-2.7M
+0.09%
Net Income from Continuing Operations Applicable to Common
-19.8M
-66.41%
-58.9M
+2,826.43%
-2.0M
-35.61%
-3.1M
-6.90%
Basic EPS and Net Income
-17.62
+18.65%
-14.85
+74,150.00%
-0.02
-98.89%
-1.80
+3,500.00%
Diluted EPS and Net Income
-17.62
+18.65%
-14.85
+74,150.00%
-0.02
-98.89%
-1.80
+3,500.00%
Basic Weighted Average Shares
1.1M
-71.68%
4.0M
-95.33%
85.0M
+4,791.03%
1.7M
-97.45%
Diluted Weighted Average Shares
1.1M
-71.68%
4.0M
-95.33%
85.0M
+4,791.03%
1.7M
-97.45%
Balance Sheet
Cash and Cash Equivalents
832,006
+6,782.91%
12,088
-42.67%
21,085
+109.86%
10,047
+147.04%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
832,006
+6,782.91%
12,088
-42.67%
21,085
+109.86%
10,047
+147.04%
Total Current Assets
8.5M
+2.27%
8.4M
+32,732.11%
25,441
+33.63%
19,039
+26.67%
Accumulated Depreciation
27,397
+9.25%
25,078
-1.82%
25,543
+1.64%
25,130
-5.53%
Property and Plant and Equipment and Net
3,915
N/A
N/A
N/A
N/A
N/A
302
-85.07%
Total Long-Term Assets
3,915
-98.66%
291,773
+975.98%
27,117
+8,879.14%
302
-85.07%
Total Assets
12.8M
-34.90%
19.6M
+27,028.87%
72,365
+19.95%
60,328
-26.11%
Income Taxes Payable
115,000
N/A
N/A
N/A
N/A
N/A
84,000
0.00%
Total Short-Term Debt
N/A
N/A
1.1M
+24.24%
870,267
+90.92%
455,819
-55.09%
Total Current Liabilities
3.4M
-39.87%
5.6M
+47.08%
3.8M
+20.09%
3.2M
+3.11%
Total Long-Term Debt
261,134
+147.22%
105,627
+80.12%
58,642
-88.16%
495,469
-55.54%
Total Long-Term Liabilities
23,818
-83.84%
147,376
+151.31%
58,642
+204.19%
19,278
-54.45%
Total Liabilities
3.4M
-41.00%
5.7M
+48.66%
3.9M
+21.21%
3.2M
+2.33%
Retained Earnings
-144.5M
+15.02%
-125.6M
+88.34%
-66.7M
+3.11%
-64.7M
+5.08%
Total Stockholders Equity
N/A
N/A
N/A
N/A
-3.8M
+21.23%
-3.1M
+3.09%
Total Shares Outstanding
3.3M
-71.49%
11.6M
-97.57%
478.8M
+7,838.69%
6.0M
-97.26%
Cash Flow
Cash from Operating Activities
-5.7M
+1,302.54%
-405,168
-56.67%
-935,118
-15.39%
-1.1M
-23.05%
Capital Expenditures
4,933
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-4,933
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.5M
+1,215.79%
490,756
-47.90%
941,894
-15.43%
1.1M
-25.29%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-122.15%
-79.58%
-598.08%
-78.20%
-2,743.97%
-26.79%
-3,747.83%
-33.20%
Return on Equity
N/A
N/A
N/A
N/A
52.80%
-39.07%
86.65%
-0.72%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.55
+70.07%
1.50
+22,249.25%
0.007
+11.67%
0.006
+22.45%
Cash Ratio
0.25
+11,172.73%
0.002
-60.71%
0.006
+75.00%
0.003
+146.15%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
-0.25
-19.46%
-0.31
-56.67%
Debt-to-Assets Ratio
N/A
N/A
0.06
-99.53%
12.84
-18.60%
15.77
-39.54%

Earnings & Revenue History

Debt-to-Assets

Cash Flow